dr. pal on rcs in metastatic urothelial carcinoma
Published 10 years ago • 252 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:03
dr. pal on the sequencing of immunotherapy for urothelial carcinoma
-
1:02
dr. pal on the mutational burden in bladder cancer
-
0:48
dr. pal on preoperative immunotherapy in patients with rcc
-
0:48
dr. pal discusses the role of pd-l1 in metastatic rcc
-
2:00
dr. pal on adjuvant therapy of renal cell carcinoma
-
1:25
dr. balar on imvigor 210 results for metastatic urothelial carcinoma
-
0:38
dr. siefker-radtke on fda approval of avelumab in bladder cancer
-
1:21
dr. o’donnell on pd-l1 testing in bladder cancer
-
53:56
michael denck - albumin carrier therapie (act) - ein neuer therapieansatz bei tumoren & metastasen
-
19:54
ct of the bladder: pearls and pitfalls
-
26:20
management of non-muscle invasive bladder cancer
-
1:08
dr. rafii on durvaluamb in patients with urothelial bladder cancer
-
0:34
can bladder cancer be cured? | urochannel
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
0:59
new option to control bladder cancer
-
3:32
value of pd-l1 testing in metastatic urothelial cancer
-
7:06
pd-l1 in metastatic bladder cancer - bladder cancer video library
-
1:08
dr. balar on pd-l1 testing for urothelial cancer
-
6:03
pd-l1 expression in metastatic urothelial cancer
-
1:19
dr. siefker-radtke on advancements in small cell urothelial cancer
-
0:50
real questions | bladder cancer | ucla urology
-
1:20
pooled analysis of avelumab in bladder cancer